Lee Janet Lok Chun, Wong Arnold Y L, Ng Peter H F, Fu S N, Fong Kenneth N K, Cheng Andy S K, Lee Karen Nga Kwan, Sun Rui, Zhang Hao Yi, Xiao Rong
Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, China (Hong Kong).
Research Institute for Smart Ageing, The Hong Kong Polytechnic University, Hong Kong, China (Hong Kong).
JMIR Mhealth Uhealth. 2025 Jun 5;13:e69259. doi: 10.2196/69259.
Engaging in an adequate amount of physical activity (PA) serves as a protective factor against frailty. While previous PA interventions have been effective in improving physical functioning outcomes, they have not consistently succeeded in sustaining PA behavioral changes.
The primary aim of this pilot randomized controlled trial (RCT) is to explore the feasibility and acceptability of an integrative mobile health (mHealth) intervention among community-dwelling older adults with prefrailty and frailty. The secondary aim was to investigate the potential effects of the intervention on sustaining PA levels and improving mental well-being and exercise self-efficacy in this population.
A 2-armed pilot feasibility randomized controlled trial was conducted. A total of 38 inactive, community-dwelling older adults (aged>55 years) with prefrailty and frailty were randomized to either the intervention group (n=19), which received 4 weekly educational workshops at a university and a mobile app to support their use of outdoor exercise facilities in their neighborhood, or the control group (n=19), which received 4 weekly health education workshops with exercise experiential sessions tailored for older adults with frailty. To assess the acceptability of the intervention, individual semistructured interviews were conducted with, and a self-developed questionnaire was administered to, 14 participants from the intervention group.
The mean age of the participants was 71.8 (SD 9.34) years, and 24 out of 34 (71%) were female. As many as 34 participants out of 38 (89%) completed the study (18/19 in the control group and 16/19 in the intervention group). Workshop attendance rates were very high in both groups (intervention group, 63/68, 93%, and control group, 72/76, 95%). Self-reported adherence to the unsupervised outdoor practical sessions and engagement with the app was over 65% (36/51, 71%, and 35/51, 69%, in the intervention group. Two adverse events were reported in the intervention group, and none in the control group. As hypothesized, secondary outcome analyses showed that both groups increased their PA levels immediately after the intervention; however, only the intervention group maintained this increase at the 3-month follow-up. Additionally, favorable changes in mental well-being and exercise self-efficacy were observed in the intervention group. Feasibility and acceptability data also highlighted areas for improvement that should be addressed before a larger trial.
This study provides initial proof-of-concept evidence for the integrative mHealth intervention. However, modifications are needed to enhance user adherence to both the mobile app and the outdoor practice component before proceeding to a larger trial.
ClinicalTrials.gov NCT06326710; https://clinicaltrials.gov/ct2/show/NCT06326710.
进行适量的体育活动是预防身体虚弱的保护因素。虽然先前的体育活动干预在改善身体功能结果方面有效,但它们在持续维持体育活动行为改变方面并非一直成功。
这项初步随机对照试验(RCT)的主要目的是探讨综合移动健康(mHealth)干预在社区居住的虚弱前期和虚弱老年人中的可行性和可接受性。次要目的是研究该干预对维持该人群体育活动水平以及改善心理健康和运动自我效能的潜在影响。
进行了一项双组初步可行性随机对照试验。共有38名不活动的、社区居住的年龄大于55岁的虚弱前期和虚弱老年人被随机分为干预组(n = 19),该组在一所大学接受4次每周一次的教育工作坊,并使用一款移动应用程序来支持他们使用邻里的户外锻炼设施;或对照组(n = 19),该组接受4次每周一次的健康教育工作坊以及为虚弱老年人量身定制的运动体验课程。为评估干预的可接受性,对干预组的14名参与者进行了个人半结构化访谈,并发放了一份自行编制的问卷。
参与者的平均年龄为71.8(标准差9.34)岁,34名参与者中有24名(71%)为女性。38名参与者中有34名(89%)完成了研究(对照组18/19,干预组16/19)。两组的工作坊出勤率都很高(干预组63/68,93%;对照组72/76,95%)。自我报告的对无监督户外实践课程的依从性以及对应用程序的参与度超过65%(干预组分别为36/51,71%和35/51,69%)。干预组报告了两起不良事件,对照组无不良事件报告。如假设的那样,次要结果分析表明,两组在干预后立即提高了体育活动水平;然而,只有干预组在3个月随访时维持了这一增长。此外,干预组在心理健康和运动自我效能方面观察到了有利变化。可行性和可接受性数据还突出了在进行更大规模试验之前应解决的改进领域。
本研究为综合移动健康干预提供了初步的概念验证证据。然而,在进行更大规模试验之前,需要进行改进以提高用户对移动应用程序和户外实践部分的依从性。
ClinicalTrials.gov NCT06326710;https://clinicaltrials.gov/ct2/show/NCT06326710 。